Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05455294 |
|
Recruitment Status :
Recruiting
First Posted : July 13, 2022
Last Update Posted : July 25, 2023
|
Sponsor:
Jacqueline Garcia, MD
Collaborator:
AbbVie
Information provided by (Responsible Party):
Jacqueline Garcia, MD, Dana-Farber Cancer Institute
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | December 31, 2024 |
| Estimated Study Completion Date : | December 31, 2026 |